BHI Weekly Newsletter Archives Archives - Page 37 of 65

Apr 08 2018

Love0

298th Edition – April 3, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

April 3, 2018

Office of Montgomery County Executive Assistant Chief Administrative Officer Lily Qi Interviewed on BioTalk with Rich Bendis Podcast

Lily, Qi, Assistant Chief Administrative Officer – Office of Montgomery County Executive joins Rich for this episode of BioTalk. They discuss the topics like the role that MoCo plays in Economic Development, Cultural Competence in a diverse region, and her future career goals. Lily has served County Executive Ike Leggett for eight years in various capacities and led strategic initiatives including privatizing economic development functions; establishing BioHealth Innovation, Inc. to advance research commercialization; developing global partnerships; improving nighttime economy, and developing the Comprehensive Economic Strategy. Lily joined Montgomery County after serving as Vice President of Business Development and Marketing for the Washington, DC Economic Partnership and spokesperson for the DC Department of Insurance, Securities and Banking.

Listen now on iTunes , Google Play , and TuneIn.

Third Annual Crab Trap: Deadline approaching, last week to apply….

APPLY NOW »

You thought the Shark Tank was tough?

The Third Annual BioHealth Capital Region Crab Trap is now accepting applications at http://www.bhcrforum.com/crab-trap/

Deadline for entries is April 9th, 2018 – Finalists will be announced on April 17th, 2018

Submit your application for a chance to be named the startup company with the most commercial potential at the BioHealth Capital Region Forum.

Five finalists will have the chance to win the grand prize by presenting on April 24th in front of a panel of prominent industry funding expert and executives.

2018 BioHealth Capital Region Forum: Only 2 Weeks Left to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

2018 FNIH Lurie Prize in Biomedical Sciences Winner Discovered How DNA Stimulates Immune Response

The Foundation for the National Institutes of Health (FNIH) is delighted to recognize Zhijian “James” Chen, Ph.D., with the 2018 Lurie Prize in Biomedical Sciences for discovery of the enzyme cyclic GMP‐AMP synthase (cGAS) and its corresponding pathway, which solved a century- old mystery about DNA. Long before DNA was known to be a genetic material, scientists knew that it could activate the body’s immune system to fight infections. However, they did not understand the cellular process that occurred to trigger this response until Dr. Chen’s discovery. The cGAS enzyme and its DNA-sensing pathway are the catalyst for the critical immune response that defends the body against viruses, bacteria and tumors, but surprisingly, they also can inflict autoimmune disease. Now in its sixth year, the Lurie Prize in Biomedical Sciences will be presented to Dr. Chen at the FNIH Award Ceremony hosted by CNN’s Wolf Blitzer on May 16, 2018 in Washington, D.C.

Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection | Altimmune, Inc.

Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced positive data from its Phase 2a study of NasoVAX intranasal influenza vaccine and provided an update on its Phase 1b study of HepTcell targeted immunotherapy in chronic hepatitis B infection. Results from the Phase 2a study of NasoVAX™ intranasal flu vaccine in 60 healthy individuals showed 100% seroprotection in the mid- and high-dose groups. Results from the Phase 1b study of HepTCell in hepatitis B infection showed that HepTcell was well tolerated at all doses tested, while the unblinded T-cell immunogenicity results were inconclusive.

Center for Human Genomic Medicine and Research Joins JHU Montgomery County Campus – News – Johns Hopkins University Montgomery County Campus

Dr. Sisir Dutta, a former genetics professor at Howard University, has established the Center for Human Genomic Medicine and Research. The nonprofit center is a new tenant at the Johns Hopkins University Montgomery County Campus.

Cerecor Appoints Peter Greenleaf as Chief Executive Officer – Press Release – Digital Journal

Cerecor, Inc. (NASDAQ: CERC) today announced that its Board of Directors has appointed Peter Greenleaf as Chief Executive Officer. Mr. Greenleaf has served on the Company’s board since May 2017. He brings to Cerecor over two decades of biopharmaceutical experience, having most recently served as Chairman and CEO of Sucampo Pharmaceuticals and led the company’s acquisition by Mallinckrodt Pharmaceuticals for $1.2 billion. Throughout his career, Mr. Greenleaf has demonstrated a track record for creating shareholder value through solid commercial execution and efficient drug development.

BioMarker Strategies Announces that Both of Its Core Diagnostics Technologies for Solid Tumor Cancers Are Now Covered by New Patents Granted in Canada | Business Wire

The SnapPath® Cancer Diagnostics System is the only diagnostics system that can generate purified populations of live solid tumor cells from live, unfixed samples in an automated and standardized manner. SnapPath preserves the molecular integrity of these living cells for exposure outside the human body to targeted therapies. This enables the generation of PathMap® Functional Signaling Profiles, which are highly predictive of individual solid tumor response to targeted therapies and combinations, because they are based on the dynamic, predictive signaling information available only from live cells. BioMarker Strategies has been granted patents on both of these important technologies in the United States, Europe, Australia, Canada and Japan, and patent applications are pending elsewhere. (Photo: Business Wire)

Emmes and IDx Partner Using Artificial Intelligence to Detect Diabetic Retinopathy in Primary Care

The Emmes Corporation today announced the completion of a pivotal clinical trial for a new product developed by IDx that could help in detecting diabetic retinopathy, the leading cause of blindness in the United States. IDx-DR is a fully autonomous AI-based diagnostic system that analyzes images of the retina for signs of diabetic retinopathy, providing instructions for follow-up care based on the level of disease detected. IDx-DR has been granted expedited review by the Food and Drug Administration.

2017 Year-End Market Report — MCEDC

Montgomery County continues to experience a steady rise in employment since 2014, a positive change from stagnant growth in prior years. Montgomery County recorded over 550,000 employees, an increase of 2.6% from last year and trended above the then year average of 516,360. Montgomery County’s unemployment rate continued to contract and ended Q3 2017 with a rate of 3.2%, down from 3.3% from November 2016.

BioBuzz with Hogans Agency, Inc. – April 19th

Join BioBuzz and founding sponsor Hogans Agency at Bar Louie on April 19th. Hogans Agency, Inc. has more than 60 years of insurance industry experience and over 20 years experience serving the Life Science insurance segment. We draw upon this expertise as we work to understand the changing nature of our client’s business.

Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company’s Growth Strategy NYSE:EBS

Emergent BioSolutions Inc. (NYSE:EBS) today announced executive management changes that continue to align its organizational structure to its long-term strategy and to the achievement of its near- and long-term growth objectives. Specifically, effective today, the company’s board of directors promoted Robert G. Kramer Sr. to the newly-created position of president and chief operating officer, and appointed Richard S. Lindahl as the company’s new executive vice president and chief financial officer.

NexImmune Announces Management and Board Appointments

NexImmune, an emerging leader in the field of antigen-directed immunotherapy, today announced that Scott Carmer has been appointed Chief Executive Officer. Mr. Carmer has served as NexImmune’s Chief Operating Officer since 2015. In addition, Kristi Jones has been promoted to Chief Operating Officer, and Alan Roemer has been appointed as Chairman of the Board of Directors.

GSK buys out Novartis in $13 billion consumer healthcare shake-up

GlaxoSmithKline (GSK.L) is buying Novartis (NOVN.S) out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches.

PA-18-702: Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp – Clinical Trial Not Allowed)

The purpose of the administrative supplement is to provide support for NIH-funded investigators to participate in an entrepreneurship training course, the Concept to Clinic: Commercializing Innovation (C3i) Program. The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation. Prospective applicants are strongly encouraged to contact NIH Scientific/Research staff for more information about the program before applying.

Funding Early Stage Companies: Guidance from the Deerfield and NextCure

When: Thursday, April 19, 2018 4:00 – 7:00 PM EST

Where: Johns Hopkins Technology Ventures 1812 Ashland Avenue Baltimore, MD 21205

Deerfield Management is an investment management firm, committed to advancing healthcare through investment, information and philanthropy. Partner and Hopkins alum, Brian Bizoza, MD will talk to their investment strategy and their work advancing early technologies from major academic institutions.

JHU Launches New Concentration in Regenerative and Stem Cell Technologies – News – Johns Hopkins University Montgomery County Campus

Johns Hopkins University is launching a new concentration in Regenerative and Stem Cell Technologies within the Master of Science in Biotechnology. Students will become knowledgeable about areas including regenerative medicine, cell therapy, gene therapy and tissue engineering.

Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System – Senseonics

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced a favorable outcome of the U.S. Food and Drug Administration (FDA) Clinical Chemistry and Clinical Toxicology Devices meeting on the Eversense system. The panel, comprised of independent medical experts, voted unanimously, 8 to 0, that the benefits outweigh the risks, voted unanimously, 8 to 0, that the system is safe, and voted unanimously, 8 to 0, that the system is effective.

WeWork to Open First Maryland Location on University of Maryland Campus – UMD Right Now

Adding to the growing momentum in Prince George’s County, WeWork, a global leader in coworking with more than 200 locations in 21 countries around the world, has selected College Park for its first location in the State of Maryland. As part of a new partnership model, this will be the first WeWork on a college campus, located in the University of Maryland’s Discovery District.

The South’s Most Active Startup Investors – TEDCO Listed

The American South is not all barbecue and shrimp and grits. It turns out that there are plenty of interesting startup companies in the region, and where there are startups, there are investors too.

Student-run incubator gets startups off the ground – Hub

You’re a student, and you’ve got an idea for a new app. It’s handy. It’s intuitive. It solves some commonplace problem you’ve encountered yourself too many times to count. This idea of yours is going to take off, you know it.

Blockchain, AI and robotics: How future tech will simplify federal procurement

Created in 1974, the Federal Acquisition Regulation provides “uniform policies and procedures for acquisition” to ensure integrity, fairness, and openness in federal procurement. And for over 40 years now, federal agencies have implemented numerous contract writing and support systems. But no one technology has made it dramatically easier for contracting officers or industry.

Mar 27 2018

Love0

297th Edition – March 27, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

March 27, 2018

Montgomery County Council Approves Biotech Grant Program | Montgomery Community Media

The Montgomery County Council on Tuesday unanimously approved Tuesday a county matching fund for businesses that receive federal grants.

Councilmember George Leventhal spearheaded the grant, which was co-sponsored by the eight remaining council members.

New York firm leads $40M Series A for Baltimore-based Dracen Pharmaceuticals – Technical.ly Baltimore

A biotech company founded by Johns Hopkins researchers to develop new drugs to fight cancer said this week that it is raising $40 million in Series A funding.

The round for Dracen Pharmaceuticals was led by Deerfield Management Company, a New York–based firm which invested $36 million in the round.

TEDCO’s Seed Fund invested $1.2 million in these 5 startups – Technical.ly Baltimore

TEDCO announced investments from its seed fund in five startups this week, including three from Baltimore.

Taken together, the latest funding from Maryland’s quasi-public agency backing early-stage companies totals $1.2 million. Here’s the funding breakdown:

The State of the Healthcare Industry and the Impact on Investment Banking/Capital Markets – BHI CEO Rich Bendis to Speak

Wednesday, April 18, 20185:00 PM – 8:00 PM

Please join us on Wednesday, April 18, 2018 for a Healthcare Panel presentation and networking event at the INOVA Personalized Health Conference Center.

Cocktails and hors d’oeuvres will be provided.

Novavax details ‘pre-commercialization activities,’ $1.5B sales target for RSV vaccine | FiercePharma

Novavax may be years away from a potential approval of its RSV vaccine, but on the company’s recent year-end conference call, executives talked up the candidate’s commercial appeal and the steps they’re taking now to prepare for a possible rollout.

Alexandria Real Estate Equities, Inc. Appoints Jennifer J. Banks and Larry J. Diamond as Co-Chief

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, today announced that its board of directors has appointed Jennifer J. Banks and Larry J. Diamond as co-chief operating officers, effective April 23, 2018. Ms. Banks will assume additional responsibilities related to leading the company’s risk management operations and will continue as general counsel and corporate secretary. Mr. Diamond will assume a national role overseeing the company’s real estate property operations and will continue as regional market director of Maryland.

How Martine Rothblatt and James Park Are Using Big Data – Fortune

In some ways Martine Rothblatt, the founder and chairwoman of United Therapeutics, a Maryland-based biotechnology company, and James Park, the CEO and co-founder of consumer fitness company Fitbit, are unusual health care leaders and entrepreneurs. Both came from outside the industry—Rothblatt previously created SiriusXM radio, among other things; meanwhile the inspiration for Park’s popular family of wearable devices was the Nintendo Wii— and neither set out steeped in the regulatory arts of American healthcare.

Maryland Senate approves Amazon HQ2 incentive package – Washington Business Journal

The Maryland state Senate signed off on $5.6 billion in tax incentives to lure Amazon.com Inc. to Montgomery County on Monday night.

Baltimore and BHI Client medical device startup Perceptive Navigation LLC looks to raise $4 million – Baltimore Business Journal

Baltimore medical device firm Perceptive Navigation LLC is looking to raise $4 million in new funding, according to a recent filing with the U.S. Securities and Exchange Commission.

How Baltimore’s Harpoon Medical secured an exit strategy 2 years before its $100M acquisition by Edwards Lifesciences Corp. – Baltimore Business Journal

Investors got big returns on the initial sale and could see millions more over the coming years, as Harpoon’s device continues on the path to U.S. regulatory approval.

American Gene Technologies Gains Additional Immuno-Oncology Patent | American Gene Technologies

American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology patent on the stimulation of gamma delta T cells for treating solid tumors in epithelial cancers. U.S. Patent No: 9,914,938 dated March 13, 2018 further consolidates AGT’s intellectual property position surrounding its novel gene therapy platform. The patent describes AGT’s unique lentivirus vector approach to modify tumors for potent activation of naturally-occurring T cells in the immune system providing a highly-effective immune response and destruction of tumors.

2018 BioHealth Capital Region Forum: Time to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

2018 BHCR Crab Trap: Last week to apply to win $10,000 and present to world class judges

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Innovation Village ready to bring startup resources, venture capital together in new Baltimore HQ – Baltimore Business Journal

Eighteen companies ranging in maturity and focus, from software building to bag making, will be housed in the newly renovated HQ by the end of the month.

These two Baltimore biotech hubs are partnering to help scientist-entrepreneurs – Technical.ly Baltimore

A pair of bio-oriented spaces in Baltimore are looking to provide extra help to scientists building companies out of discoveries.

The Inner Harbor–based Institute of Marine and Environmental Technology (IMET) and Baltimore Under Ground Science Space (BUGSS) have a new partnership, according to leaders from both spots.

Johns Hopkins leads all U.S. universities in research spending for 38th year in a row | Hub

Johns Hopkins University led all U.S. universities in research and development expenditures for the 38th consecutive year in fiscal year 2016, spending $2.431 billion on projects like fighting dengue, finding the functional age of cells, and explaining why the universe is making fewer stars.

WellDoc Announces Formation of Scientific Advisory Team

WellDoc®, a leading digital therapeutic company, announces today the formation of its scientific advisory team whose expertise spans cardiology, health behavior, endocrinology, primary care and pharmacy-based diabetes education and care. Richard Katz, MD, Janet Duni, RN, BSN, MPA, CCM, Pablo Mora, MD, Nancy D’Hondt, RPh, CDE, FAADE, Edwin Fisher, PhD and Charlene Quinn, PhD have each been involved in WellDoc’s digital health journey with product enhancement, evaluation, or implementation and have been asked to now formally serve as scientific advisors to the company.

CASI Pharmaceuticals Announces $50 Million Private Placement To Prepare Company For Commercialization In China

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces today a $50 million private placement. The Company has entered into definitive securities purchase agreements pursuant to which the Company will issue 15,432,091 shares of its Common Stock with accompanying warrants to purchase 6,172,832 shares of its Common Stock. The purchase price for each share of Common Stock and warrant is $3.24. The warrants will become exercisable 180 days after issuance at a $3.69 per share exercise price, and will expire five years from the date of issuance. On March 19, 2018, the consolidated closing bid price per share of Common Stock was $3.19.

Akonni Biosystems Announces Strategic Partnership with Major Chinese Diagnostics Company Righton

Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, announce a commercial agreement that enables Righton to sell Akonni’s products for nucleic acid purification and molecular diagnostics to researchers, clinical laboratories, and hospitals in China. The products to be sold include TruTip®, Akonni’s best-in-class sample preparation technology, which is low-cost and simple, yet highly effective at purifying DNA and RNA from the most difficult sample types. In addition, for diagnostic applications, Righton plans to commercialize Akonni’s TruDiagnosis® system based on the proprietary TruArray® multiplexed diagnostic solutions. Righton has made an equity investment of $7.5 million USD in Akonni’s series D fundraising round bringing the total investments in the Series D round to $13.9 million USD.

A whopping 80 percent of all venture capital investment goes to just three states. That has to change. – Recode

Our country faces an ever-growing number of challenges in the 21st century, but all too often our political dialogue can’t even begin to scratch the surface. While Washington remains mired in its usual partisan fights, entire communities across the country — especially in the Midwest — have been locked out of an economy that has moved away from the manufacturing base that helped build the strongest middle class the world has ever seen.

MCCC GovConNet Procurement Conference – Pathway to Growth

Friday, May 18, 2018 7:30AM – 3:00PM

Largest Regional Small Business Procurement Conference

MCCC GovConNet Procurement Conference gives over 800 attendees the unique opportunity to gain valuable insights and meet directly with key purchasing agents from a variety of prime contractors and federal, state, and local government agencies.

Lupin launches generic Lodosyn® tablets in the US

Pharma major Lupin announced the launch of its Carbidopa Tablets 25mg having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Carbidopa Tablets, 25mg is the generic equivalent of Aton Pharma, Inc.’s Lodosyn® Tablets, 25 mg. It is indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism, which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication.

See How Much Your Agency’s Spending Would Increase Under the 2018 Omnibus – Oversight – GovExec.com

The $1.3 trillion fiscal 2018 funding package sent to President Trump early Friday includes big boosts for almost all of the major federal agencies, thanks to a broader two-year budget deal increasing spending caps that President Trump signed last month.

HHS Secretary Azar to Name Robert R. Redfield, M.D., Director of the Centers for Disease Control and Prevention | HHS.gov

On Wednesday, the Department of Health and Human Services announced that Secretary Alex Azar will name Robert R. Redfield, M.D., as the 18th Director of the Centers for Disease Control and Prevention and Administrator of the Agency for Toxic Substances and Disease Registry.

AACR president-elect to focus on health disparities, convergence science

Elizabeth M. Jaffee, MD, will become president of American Association for Cancer Research next month.

Jaffee is deputy director of Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, as well as associate director of Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins.

Maryland, Anne Arundel County Announce Support for Paragon Bioservices’ Expansion

The state of Maryland and the Anne Arundel County Economic Development Corp. (AAEDC) announced today their support of Paragon Bioservices’ new commercial manufacturing facility under development in Anne Arundel County and the addition of 200 new jobs over the next four years. Earlier this year, Paragon, a leading biologics contract development and manufacturing organization (CDMO) with expertise in gene therapy and next-generation vaccines, announced plans to lease 150,000 square feet in the BW Gateway development on Harmans Road.

Jeff Vinik’s latest big investment: $12 million in startup accelerator Dreamit

Tampa Bay Lightning owner and developer Jeff Vinik is investing $12 million in Dreamit, an early-stage venture fund and startup accelerator with offices in New York, Philadelphia and — in the foreseeable future — Tampa.

Here Are All the Ways Sugar Is Actually Killing You

Do you find it nearly impossible to resist the opportunity to devour a cupcake, brownie, or doughnut? You’re not alone. Most of us jump at the chance to satisfy our sweet tooth, even though we know it isn’t good for us. Too many people, however, take an all-or-nothing approach when it comes to junk food, which can make it hard to quit. You don’t have to stop eating sugar completely, but eating less of it could improve and even save your life.

In 1887, Nurses Had To Follow These 9 Ludicrous Rules

If you’ve been to the hospital recently, you’ve probably noticed that the hospital relies on nurses in order to keep everything running smoothly. In fact, according to the United States Bureau of Labor Statistics, there are over 3.1 million nurses in the United States alone.

The Struggle to Build a Massive ‘Biobank’ of Patient Data – The New York Times

This spring, the National Institutes of Health will start recruiting participants for one of the most ambitious medical projects ever envisioned.

Twitter for Scientists: an Idea Whose Time Has Finally Come? – The Chronicle of Higher Education

Tweeting has long posed a dilemma for scientists. There’s abundant evidence that widely sharing a research finding in just one or two simple sentences greatly increases its use and effectiveness.

Scientists launch global effort to find the next diabetes drug – ScienceBlog.com

USC researchers have launched a massive scientific effort to construct a detailed, virtual 3-D model of the pancreatic beta cell and its components — a global project that aims to one day curb the worldwide rise of diabetes.

Mar 20 2018

Love0

296th Edition – March 20, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

March 20, 2018

Montgomery County Economic Development Corporation (MCEDC) CEO of MCEDC, David Petr, Joins Rich Bendis for Latest Episode of the BioTalk Podcast

This discussion covers how David arrived in Maryland, the role of MCEDC in the BioHealth Capital Region, and why Montgomery County is a great place to do business.

Before becoming the inaugural President and CEO of MCEDC, David was with the Central Florida Development Council, where as President and CEO, he achieved record-setting job creation and capital investment results. Previously, David was the Executive Director of the Winter Haven Economic Development Council in Florida. In Texas, he has held key marketing management positions in economic development and was an advertising agency owner in Austin.

Listen now on iTunes , Google Play , and TuneIn.

FDA Breakthrough Device Designation for blood infection test

The FDA’s drive to accelerate access to new medical device technologies continues, with a new product from 3i Diagnostics receiving a Breakthrough Device Designation.

ExeGi Pharma Launches High Potency Veterinary Probiotic To Help Manage GI Tract Illnesses In Dogs

ExeGi Pharma LLC, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today that it has launched Visbiome® Vet, a new high potency probiotic for use in dogs to help support normal inflammatory responses in the gastrointestinal (GI) tract and to help normalize gut health.

2018 BHCR Crab Trap: Only a month left register to win $10,000 and present to world class judges

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Novavax CEO Stanley Erck calls last quarter ‘the most significant in Novavax corporate history’ – Washington Business Journal

Novavax CEO Stanley Erck said he believes the last quarter was “the most significant in Novavax corporate history.”

The reason? Vaccines, specifically clinical results from the Gaithersburg company’s two lead vaccine programs: RSV for infants via maternal immunization and NanoFlu for seasonal flu.

How to Boost Biotech in Montgomery County – YouTube

Jarrod Borkat of MedImmune says what would help MedImmune would be other large biotech companies located in Montgomery County. Although he expects his company would lose talent, it would be a net gain.

Baltimore medical device startup Perceptive Navigation LLC looks to raise $4 million – Baltimore Business Journal

Baltimore medical device firm Perceptive Navigation LLC is looking to raise $4 million in new funding, according to a recent filing with the U.S. Securities and Exchange Commission.

2018 BioHealth Capital Region Forum: Time to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

UMBC’s president is an activist, innovator and ‘mega nerd.’ His latest role: Giddy basketball fan – The Seattle Times

Freeman Hrabowski III, the university president and most notable dreamer at Maryland Baltimore County, didn’t close his eyes until 6 a.m. Saturday. He had too many text messages to answer, too many calls to take, too many voice mails to retrieve. He had too many people to hug, too many whys and hows to try to explain, too many Friday night thrills to relive.

How Much Can a University Make of a March Madness Cinderella Story? – The Chronicle of Higher Education

At halftime, with players locked in a surprising tie with the top-ranked men’s basketball team in the country, the Twitter feed of the University of Maryland-Baltimore County’s athletic department seized the spotlight to make a sales pitch.

Who is University of Maryland, Baltimore County?

The University of Maryland, Baltimore County woke up on Friday as just another small basketball program looking forward to a run against a No. 1 seed in the NCAA tournament.

Maryland’s ‘internet creators’ added $101.3M to the state’s economy in 2016 – Baltimore Business Journal

Platforms such as Amazon Publishing, Etsy and Instagram have yielded an entire new market of online artists and creators.

Roche buys Flatiron Health for $2.1 billion – Axios

Roche is buying out the rest of Flatiron Health for $1.9 billion, the companies said Thursday. The total investment for Roche, a drug maker based in Switzerland, is about $2.1 billion in cash since it already owned about 13% of Flatiron, a tech company that handles electronic health records and data mining specifically for cancer doctors, researchers and patients.

Lupin launches generic Safyral® tablets in the US

Pharma major Lupin announced the launch of its Tydemy™ Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.

20K Value Research Prize Could be Yours!

The Maryland Tech Council and SoBran are celebrating the transformational science coming out of Maryland and surrounding area by establishing the Innovation for Impact Prize. This is an added annual award at the Industry Awards Celebration. Tell us how your innovative research will impact the world one day and describe your research! Deadline to apply is April 17, 2018.

Healthwise and GetWellNetwork Deliver Award-Winning Health Education

Healthwise and GetWellNetwork® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over 600 Healthwise patient education videos to its current suite of patient experience technologies that deliver Precision Engagement™ across the care continuum.

Baltimore Emerging Technology Center Ranked 7th in UBI’S World Incubator Summit Awards for World of Top Business Incubator – Collaborating with University

ETC (The Emerging Technology Centers), Baltimore City’s technology and innovation center and award-winning entrepreneur support organization, was ranked seventh, globally, in UBI’S World Incubator Summit Awards for World of Top Business Incubator – Collaborating with University.

ETC announces new seven-member, 2018 Accelerate Baltimore cohort – Baltimore Business Journal

Emerging Technology Centers announced the seven companies that have been accepted into its 2018 Accelerate Baltimore cohort.

Scheer Partners represents Supernus Pharmaceuticals, Inc

Scheer Partners, the leading provider of fully integrated commercial real estate services in the Washington and Baltimore metropolitan areas, announced today that it has negotiated on behalf of Supernus Pharmaceuticals, Inc., a 118,000-square-foot headquarters lease at 700 Quince Orchard Road, a building owned by the Rock Creek Fund.

Hopkins Spin-Out Proscia Inks Agreement to Bring Deep Learning Technology to Dermatopathology

Proscia Inc., creators of AI-powered digital pathology software, today announced it has signed a first-of-its-kind agreement with one of the largest dermatopathology labs in the country, signaling Proscia’s entrance into the dermatopathology market and ushering in a new era of digital and computational pathology applied to dermatology.

UMD Researchers Fearlessly Pursue Solutions in Health, Security, Energy, and More – UMD Division of Research

The year 2017 marked yet another exciting period of innovation and growth for the University of Maryland (UMD) research community, with over 170 inventions disclosed and 52 patented, 46 technologies licensed, and the receipt of the largest investment in UMD history in total of $219.5 million from the A. James and Alice B. Clark Foundation. Researchers broke barriers in fields related to agriculture, information management, biotechnology, and energy, making discoveries and inventing technologies that have the potential to make positive impacts on the planet and on people’s lives around the globe.

Johns Hopkins scientists genetically engineer malaria-resistant mosquitoes – Fox News

Mosquitoes are bad news when it comes to the spread of malaria, a deadly disease which kills hundreds of thousands of people each year. We previously covered a range of approaches to cracking down on this problem — ranging from apps which track disease-carrying mosquitoes by listening to their buzz to a plan to release genetically engineered killer mosquitoes to hunt down their disease-carrying wild counterparts.

Kaiser Permanente, Village Capital unveil 10 startups in Health: US 2018 program – MedCity News

Village Capital, a venture capital firm, and Kaiser Permanente have teamed up to address the needs of the aging population in America through a new program called Health: US 2018.

8 women medtech innovators you need to know – Medical Design and Outsourcing

As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine.

Mid Atlantic Bio Angels Initiates Second Investment Pool and Makes Inaugural Investment in POP Medical Solutions, Ltd. | StockGuru SmallCap Alerts on Penny Stocks

Mid Atlantic Bio Angels (MABA) announces today the initiation of a second closed-end investment pool (Pool II) funded by current, active MABA members, and the inaugural investment from that pool made into Israel-based POP Medical Solutions Ltd., which focuses on the treatment of pelvic organ prolapse (POP).

Become a USDA SBIR Success Story! – Webinar

Wed, Apr 11, 2018 2:00 PM – 3:30 PM EDT

USDA ARS and the USDA SBIR program formed a partnership to encourage USDA SBIR applicants to develop research collaborations with ARS scientists and/or to license ARS technologies. The purpose is to increase the likelihood of success by providing both money and technologies to small U.S. businesses. The relevant language in the SBIR’s “Request for Application” states: “Additional factors that will be considered in the review process include whether an application involves a Cooperative Research and Development Agreement (CRADA) with a USDA laboratory, or a license to a USDA technology, or is a resubmission.”

Why the Pharmaceutical Industry is Booming in Japan – SPONSOR CONTENT FROM THE GOVERNMENT OF JAPAN

Older people need more medicine. That rule of life is no secret to pharmaceutical companies across the globe. Many also realize that Japan’s rapidly aging population presents a unique business opportunity. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. The lessons learned there will be critical as the population grows older in many other markets.

New state website is designed to answer entrepreneurs’ start-up questions – Baltimore Sun

The Maryland Department of Assessments and Taxation unveiled a new website Monday designed to help small business owners and entrepreneurs plan, start, manage and grow their businesses.

Mar 13 2018

Love0

295th Edition – March 13, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

March 13, 2018

2018 BHCR Crab Trap: Apply Now!

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

2018 BioHealth Capital Region Forum: Time to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

SBIR Application Support

Have you drafted your application for the April 5th SBIR Funding application deadline? For qualified companies, BioHealth Innovation, will provide an additional review and support. If interested, email BHI@BIoHealthInnovation.org by this Friday, March 16th.

Supernus Pharmaceuticals shifts headquarters from Rockville to Gaithersburg – Washington Business Journal

After a year of surging growth, Supernus Pharmaceuticals Inc. is building out a new home double its current size.

PointClickCare and Redox to Bridge the Gap Between Acute and Post-Acute Markets with Strategic Partnership | Business Wire

PointClickCare Technologies, the leading cloud-based software vendor for the long-term and post-acute care (LTPAC) market, announced today its strategic partnership with Redox Inc., the leading integration platform for healthcare data exchange. Together, PointClickCare and Redox will work to bridge the gap between the acute and post-acute markets, empowering health systems with the visibility required for a truly coordinated and collaborative approach to care delivery across the healthcare continuum.

Participate in Summer RISE 2018!

Summer R.I.S.E. (Real Interesting Summer Experience) is a unique opportunity for Montgomery County youth to explore potential careers and for our local businesses to participate in developing a talent pipeline. The initiative is led by WorkSource Montgomery, Inc. (WSM), Montgomery County Public Schools (MCPS) and supported by county and state government partners, local businesses and non-profit organizations. Local businesses and governmental organizations volunteer to bring rising high school juniors and seniors into their workplaces to provide hands‐on, real world career experiences.

High Visibility Opportunities for Small Companies at BIO 2018

Will Your Company be the Buzz of BIO?

Are you an innovative biotech company that is R&D-intensive and looking to develop strategic partnerships within the industry? Nominate your company to be the Buzz of BIO!

Winners receive complimentary registration that includes BIO One-on-One Partnering™, a Company Presentation slot in the BIO Business Forum, and marketing promotion to thousands of industry leaders.

Nominations End March 16

CMS Chief Seema Verma Unveils 2 EHR Platforms at HIMSS Annual Conference

The Centers for Medicare and Medicaid Services has announced a new initiative designed to provide patients access to their electronic health records and share their data with their preferred health care providers.

Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results

Life science industry impacts N.J. economy in big way, C&W report says – ROI-NJ

Life science industry impacts N.J. economy in big way, C&W report says By Emily Bader New Jersey | Mar 7, 2018 at 11:44 am

The life science industry is fueling New Jersey’s economy through revenue and job growth, according to a report by Cushman & Wakefield.

Vanda Pharmaeuticals says Hetlioz is a big step closer to addressing jet lag disorder – Washington Business Journal

Millions of travelers suffer from jet lag every year. And now Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) said one of its drugs successfully addressed the problem with hundreds of volunteers in a late-stage clinical trial.

Sonavex Submits 510(k) Application to FDA, Dials Up Series A to $4.5M – Sonavex

Sonavex, Inc. announced today the final closure of its expanded $4.5M Series A and filing of a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its EchoMark device. The proceeds will accelerate Sonavex’s commercial launch later this year and support further product development. Participants in the additional financing included Fusion Fund (aka NewGen Capital), FundRx, and existing investors.

TEDCO Accepts ClearMask into mdPACE Program — ClearMask

TEDCO, Maryland’s economic engine for technology companies, inducts ClearMask into its mdPACE program to assist in bringing its life-changing innovation to market. Baltimore-based, ClearMask LLC is the developer of the country’s first, full-face transparent surgical mask designed to help healthcare entities reduce medical errors caused by miscommunication and provide a better experience for deaf patients and other patient groups who heavily rely on visual cues, including children, limited English proficiency patients, and immunosuppressed patients who cannot see the smiles of their loved ones and care team.

Symbiont Health Wins UMD Pitch Dingman Competition, Chaired by Robert Hisaoka – Robert H. Smith School of Business, University of Maryland

Symbiont Health, maker of innovative technology to detect falls for seniors and nursing home patients, took home the $15,000 grand prize at yesterday’s Pitch Dingman Competition, the University of Maryland’s business competition chaired by businessman and philanthropist Robert G. Hisaoka. The competition awarded nearly $30,000 in seed funding to top student entrepreneurs in a “Shark Tank”-style pitch session, hosted by the Dingman Center for Entrepreneurship at the Robert H. Smith School of Business.

23andMe Granted First FDA Authorization for Direct-to-Consumer Genetic Test on Cancer Risk – 23andMe Media Center

23andMe, Inc., the leading personal genetics company, today received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian and prostate cancer.

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care

The Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR-IMAT) solicitation is a companion SBIR funding opportunity announcement to the NCI Innovative Molecular Analysis Technologies (IMAT) Program aimed at the inception, development, integration, and application of novel and emerging technologies in support of cancer research, treatment, diagnosis, and prevention.

Stem cells could boost this Maryland baby’s heart and chance for a normal life – Baltimore Sun

Surgeons trying a new way to save the life of a baby born with half a heart stood over her open chest and waited for the FedEx box.

Free, open office hours for aspiring and current entrepreneurs

Get answers from experienced entrepreneurs and legal/business professionals on how to build a successful startup company. Receive free and impartial advice, brainstorm business strategies, investigate funding opportunities and learn about the vast resources available to entrepreneurs.

Wednesday, March 14, 2018, 4-6 p.m.

TAP Building, 387 Technology Drive, Room 1105, UMD

The real trade war won’t be fought over metals: Silicon Valley braces for tech battles – News – providencejournal.com – Providence, RI

The dispute is already underway. In August, the Trump administration initiated a sweeping investigation into Chinese trade practices, including whether Chinese firms are investing in U.S. companies to steal their technology and whether they are forcing joint ventures, pressuring American companies that invest in China to transfer technology to a Chinese partner, or hacking U.S. companies’ software.

Amazon tours D.C., Maryland and Virginia in search for new headquarters – The Washington Post

Officials from Amazon.com toured sites in Washington, Montgomery County, Md., and Northern Virginia last week — the latest sign that the tech giant is seriously considering adding a second headquarters with as many as 50,000 jobs to the D.C. area, according to officials in all three jurisdictions.

Virginia Tech Wins Fourth Annual Deloitte Foundation Cyber Threat Competition

A team of students from Virginia Tech claimed victory at the fourth annual Deloitte Foundation Cyber Threat Competition for their analysis and incident response approach to a simulated cyber event. Anirudh Bagde, Danny Colmenares, Nicholas Herman and Andy Wong, the school’s team members, each received $2,000 in scholarship money.

Epigenetics therapy shows promise in patients with lymphoma – ScienceDaily

New compounds targeting epigenetics have shown remarkable early activity in patients with lymphoma, according to data presented at the TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris, France. ESMO’s phase-I oncology meeting featured early clinical studies with BET inhibitors and EZH2 inhibitors.

Life Sciences Cloud and Infrastructure Conference (4/5)

Join ISPE Chesapeake Bay Area Chapter, Maryland Tech Council, BioHealth Innovation and ByteGrid for a one day Life Sciences Cloud & Infrastructure Conference.

Listen to speakers, including Krishna Ghosh, Ph. D., Senior Policy Advisor at the Food and Drug Administration, and the co-chairs of the GAMP Cloud Special Interest Group and get a behind-the-scenes data center tour of ByteGrid’s flagship Silver Spring facility.

You’ll also get valuable insights into cloud adoption in the regulated Life Sciences industry, hear about updates to the revised ISPE GAMP Good Practice Guide on IT Infrastructure and much more!

The agenda and speakers are listed here: https://hubs.ly/H0b3TKs0

March 14th – BioBuzz with JHU MoCo – Rockville

Join BioBuzz and founding sponsor The Johns Hopkins University Montgomery County Campus at Bar Louie on March 14th. The Johns Hopkins University Montgomery County Campus offers part-time graduate courses in biotechnology fields. Students attend classes in the evenings and on Saturdays, enabling them to hold full-time jobs during the day. Depending on the degree area, students can fully complete their coursework in Montgomery County. Other students take some courses in Baltimore and/ or online.

Mar 06 2018

Love0

294th Edition – March 6, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

March 6, 2018

New Biotech in Gaithersburg Bringing 100 Jobs | Montgomery Community Media

A new biotech company is opening in Gaithersburg, and is bringing with it 100 new jobs in the next three to five years.

AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug – FierceBiotech

AstraZeneca has carved off six inflammation and autoimmune assets to create a new biotech, Viela Bio. The startup put together a $250 million series A round and a management team from its parent company to guide the mix of clinical and preclinical programs forward.

Win $10,000 at the 2018 BHCR Crab Trap

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Attn: Montgomery County BioHealth Companies

Did you know you are required to file for and receive a Hazardous Use Permit every year if you are storing, handling or using any hazardous substance in excess of 5 gallons or 50 pounds? (Failure to do so could result in civil and criminal penalties.) Learn how to do this at the free training session, March 8th, at the Germantown Innovation Center, hosted by BioHealth Innovation and Montgomery County’s Office of Emergency Management and Homeland Security

Bring your laptop and materials inventory to a 15 minute 1:1 meetings with County staff and they will help you register your materials as required on the County’s website. (Pre-registration for these appointments is REQUIRED).

To schedule an appointment, send your top 3 time preferences to BHI@BioHealthInnovation.org

Meeting slots are assigned on a first-come, first-served basis: 8:45, 9:00, 9:15 a.m. – Open 9:30-11:30 a.m. – Booked 11:30, 11:45 a.m. – Open 12:00, 12:15 p.m. – Open

More information: https://Hazmat.MontgomeryCountyMD.gov

Baltimore medical device firm Sisu Global Health launching first product, raising money for growth – Baltimore Business Journal

Baltimore’s Sisu Global Health Inc. is launching its first medical device product and planning for growth in 2018.

Sisu, founded in 2014, specializes in creating health technologies to solve public health problems. The company is backed by $2.1 million in funding from various sources including local investors Camden Partners, the Abell Foundation and state-backed Maryland Technology Development Corp. It also won an investment from venture capitalist and AOL co-founder Steve Case, through his Rise of the Rest initiative.

Emergent BioSolutions gets $26M contract for medical treatment – Maryland Daily Record

The Centers for Disease Control and Prevention has awarded Emergent BioSolutions Inc. a $26 million contract to continue to supply a medical treatment to the government.

Maryland Tech Council Announces the Innovation for Impact Prize and the Finalists for the 30th Anniversary Industry Awards Celebration | Business Wire

The Maryland Tech Council (MTC) has announced the finalists for its 30th Anniversary Industry Awards Celebration. Winners will be revealed at a celebration on May 17, 2018 at The Hotel at The University of Maryland. The event, which draws more than 600 executives from the technology and life science communities, celebrates individuals and companies that have made a significant impact in their sectors.

Innovation for Impact Prize – SoBran, Inc.

Tell us about the impact your research may make on the world. You could win a free pre-clinical research study valued up to $20,000 and $1,000 in cash, or additional cash prizes.

SoBran and the Maryland Tech Council are celebrating the transformational science coming out of the Maryland and surrounding area by establishing the Innovation for Impact Prize.

Partnering with Industry for Better Education in Drug Discovery – News – Johns Hopkins University Montgomery County Campus

Natalia Majewska spent the summer after her junior year at Northwestern University interning in a lab at MedImmune, the Gaithersburg, Maryland-based global biologics research and development arm of pharmaceutical giant AstraZeneca. There, she worked in a lab developing synthetic proteins.

This incubator is helping Johns Hopkins undergrads become entrepreneurs – Technical.ly Baltimore

A new incubator is helping its first companies at Johns Hopkins this school year. Run by a group of undergraduate students, The Hatchery Incubator is helping undergraduate students who are starting companies.

It’s an initiative of TCO Labs, a nonprofit organization founded by students that’s looking to provide more startup resources on campus.

D.C.-based Lavrock Ventures courts cybersecurity startups with $25 million fund – VentureBeat

Silicon Valley is home to an abundance of VC firms, all of them competing to get in on the next big deal. But VCs also exist (and succeed) outside of the Bay Area. While Washington, D.C. may not be an obvious location to establish a venture capital firm, Lavrock Ventures set its sights on the political capital. The firm announced today that it has closed its first fund at $25 million to invest in early-stage startups at the intersection of enterprise software, cybersecurity, and national security.

PGDx signs licensing deal with Memorial Sloan Kettering Cancer Center – Technical.ly Baltimore

Personal Genome Diagnostics is adding to its IP portfolio to further develop new kinds of cancer tests.

A licensing deal announced Wednesday gives the Canton-based company exclusive rights to develop and commercialize products based on a key discovery at Memorial Sloan Kettering Cancer Center in New York. Financial terms were not disclosed.

A Women’s Leadership Panel Discussion & Dinner

When: Tuesday, March 27, 2018 from 4:00 PM to 7:30 PM EDT

Where: Montgomery College Pinkney Innovation Complex: Science & Technology 20200 Observation Drive Germantown, MD 20876

Join us for our first Women in Pharma event! This community is for those in the pharmaceutical/biotech industry and is a community of mentors, resources across all levels, and provide educational sessions that will be an enabler for career success and work-life balance. All are welcome.

Return on Investment (ROI) Initiative – NIST

The National Institute of Standards and Technology (NIST) is undertaking an ambitious plan to assess Federal technology transfer efforts to enable greater “Return on Investment” (ROI) from the Federal Government’s $140 Billion annual investment in research and development (R&D). NIST is uniquely positioned to implement this initiative through our government-wide leadership role within the Department of Commerce, including delegated (link is external) regulatory authority and responsibility for annual reporting to the President and Congress.

Useful Stats: Employment in “Eds and Meds” by state | SSTI

For decades, state and local economies have leaned heavily on their anchor institutions during times of economic uncertainty and transition. An analysis finds that total employment in “Eds and Meds” industries increased in every state from 2005 to 2015. This article breaks down the growth and geography of Eds and Meds employment at the state level, while next week’s issue of the Digest will explore this data by metropolitan area.

Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate Against Zika Virus NYSE:EBS

Emergent BioSolutions Inc. (NYSE:EBS) and Valneva SE (Euronext Paris:VLA) today announced the initiation of a Phase 1 clinical trial in the U.S. to evaluate the safety and immunogenicity of VLA1601, their vaccine candidate against Zika virus.

JPMorgan wants to become the Amazon of Wall Street – Business Insider

“The first opportunity we have to delight or to upset a client is when they walk through the door either physically or virtually.”

Sounds like a tech executive, right? Jeff Bezos even? The Amazon boss often talks about delighting customers, after all, although until recently the ecommerce giant didn’t really have doors to physically walk through.

Synthetic biology startup Senti Biosciences raises $53 million – Business Insider

Senti Biosciences, a startup that’s looking to make a new treatment that’s upending how we treat cancer, just raised $53 million.

Apple launching medical clinics for employees, the latest move in tech’s healthcare innovation fight – GeekWire

Apple is launching medical clinics for its employees in the latest attempt by a large tech company to address the U.S.’s growing healthcare problem. The new project, called AC Wellness, is launching sometime in the spring, according to its new website.

New technology may protect troops from blast-induced brain injury | EurekAlert! Science News

Researchers from theUniversity of Maryland School of Medicine (UMSOM) and the University of Maryland A. James Clark School of Engineering have developed a new military vehicle shock absorbing device that may protect troops from traumatic brain injury (TBI) after a land mine blast. Over the past 18 years of conflicts in Iraq and Afghanistan, more than 250,000 troops have suffered such injuries.

BioBuzz with JHU MoCo

When: Wednesday, March 14, 2018 from 5:00 PM to 7:00 PM

Where: Bar Louie 150 Gibbs St Rockville, MD 20850

757 LAUNCH celebrates three new resources in support of Hampton Roads entrepreneurship – pilotonline.com

Entrepreneurship is on the rise in Hampton Roads and there’s an event to celebrate it.

757 LAUNCH, from 12:30 p.m. to 2 p.m. on March 30 at the Selden Market in Norfolk, will showcase three new resources to support area entrepreneurs and startups.

HIMSS acquires business accelerator Healthbox – Modern Healthcare

The Healthcare Information and Management Systems Society has acquired Healthbox, looking to tap the business accelerator for its consulting and fund management capabilities.

Big pharma, big data: why drugmakers want your health records

Studying such real-world evidence offers manufacturers a powerful tool to prove the value of their drugs – something Roche (ROG.S) aims to leverage, for example, with last month’s $2 billion purchase of Flatiron Health.

Microsite i.Invest National Youth Entrepreneur Business Competition 2018

The i.Invest Competition is designed to help entrepreneurial-minded youth, ages 13 -19, further advance their business development and pitching skills and connect with mentors, judges and investors from across the country. The competition will:

Showcase the entrepreneurial spirit of the nation’s brightest young leaders;
Provide a venue for entrepreneurs to test their business plan and pitching capabilities;
Offer opportunities for entrepreneurs to earn seed funding and connect with investors and potential customers;
Position entrepreneurs to collaborate with mentors and coaches on the development of viable business models; and
Provide opportunities for entrepreneurs to win cash and in-kind prizes.

How Precision Medicine Will Transform the Pharmaceutical and Healthcare Industries

Across the globe, a collection of healthcare professionals gather around their computer screens in their respective offices in Beijing, Brussels, London, and Los Angeles. A skilled U.S.-based oncologist leads this virtual board in discussing a 38-year-old British patient with advanced lung cancer. Using virtual reality technology, the team is able to simultaneously review the patient’s entire disease profile, including her medical history and lifestyle, and see high-resolution pathology images and all sorts of other biological data.

University of Maryland SGA wants Amazon’s new headquarters to be in Montgomery County – The Diamondback

The University of Maryland’s SGA will send a letter to Amazon supporting Montgomery County for the company’s second headquarters, called HQ2.

Feb 27 2018

Love0

293rd Edition – February 27, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

February 27, 2018

BioTech Forum: What Montgomery County Should be Doing to Foster a Healthy Environment for the Biotech Industry

New BioHealth event free to attend with excellent speakers and no registration required

Sponsored by Montgomery County Councilmember George Leventhal

Wednesday, February 28, 7-9pm at Johns Hopkins University Montgomery County Campus

Moderator:

Richard A. Bendis, President and CEO BioHealth Innovation Inc.

Panelists:

Jarrod Borkat, Senior Director, External Partnerships & Collaborations, MedImmune

Dr. Chris Austin, Director National Center for Advancing Translational Sciences (NCATS), Nation Institutes of Health

Anthony Saleh, PhD, Founder & CEO, Mirecule

Win $10,000 at the 2018 BHCR Crab Trap

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Attn: BioHealth Industry Directors

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

If you are director level or above, please register for 2018 BioHealth Capital Region Forum. This invitation-only event is free for executive level biohealth leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biohealth innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

Montgomery County Hazardous Use Permit Requirements and Registration Training

DATE AND TIME: Thu, March 8, 2018, 8:15 AM – 12:30 PM EST

LOCATION: Germantown Innovation Center, 20271 Goldenrod Lane, 2nd Floor, Germantown, MD 20876

Did you know you that, by law, you are required to file for and receive a Hazardous Use Permit* every year if you are storing, handling or using any hazardous substance in excess of 5 gallons or 50 pounds? Failure to do so could result in civil and criminal penalties.

Leveraging PostDoc Talent for Regional Industry Growth

150 post docs from the National Cancer Institute (NCI) and other institutes at NIH had the opportunity to meet BioHealth Capital Region industry leaders and discuss possible career paths in the private sector at two different events this month. The events, co-hosted by BioHealth Innovation, WorkSource Montgomery, SciPhd and BioBuzz, were held in conjunction with SciPhd workshops hosted at NIH’s main campus and at the NCI campus in Rockville which are focused on training scientists for professional careers. BioHealth Innovation is working with local partners to support the growth of the region’s biohealth industry talent pool with entrepreneurial and commercially relevant experience.

FluMist back on CDC’s recommended list of flu vaccines – UPI.com

FluMist Quadrivalent has returned to the Centers for Disease Control and Prevention’s recommended list of flu vaccines, drugmaker AstraZeneca announced.

2018 Industry Awards Celebration Finalists Announced

The Maryland Tech Council’s Industry Awards Celebration will take place on May 17, 2018 at The Hotel at the University of Maryland. This is our 30th year recognizing the high achievers in the regional technology, life science and government contracting industries.

New Microgrants to Spark Johns Hopkins’ Student Innovators – JHTV

Johns Hopkins students have access to a new funding source designed to ignite innovative ideas that may one day develop into the next great company founded by a university student.

Novavax shares moving up again – Washington Business Journal

Shares of Gaithersburg-based Novavax Inc. have spiked again, jumping by 18 percent during Friday trading, as the company is increasingly considered a promising acquisition target.

An open letter to Amazon: The D.C. region is where innovation lives – The Washington Post

Our region has a vibrant innovation ecosystem that is one of the most important in the United States. Advanced technologies that drive the country’s economy are nurtured here and further developed and deployed by our highly talented workforce and entrepreneurs. People often don’t see the scale and depth of our innovation and entrepreneurship activity because they focus on the wrong metric.

Duo of Oncology Vaccine Pioneers at the National Cancer Institute to Receive 2018 Annual

The National Foundation for Cancer Research (NFCR) announced today that the 2018 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., for development of vaccines for human papillomavirus (HPV), which causes 99% of cervical cancer cases. Collaborators for over 30 years at the U.S. National Cancer Institute (NCI) in Bethesda, Lowy and Schiller developed the first Food and Drug Administration approved vaccines specifically targeting cancer.

Press release – KeyGene’s Directed Genomic Selection Strategies Patent Upheld by European Patent Office after Opposition – Keygene

Today, KeyGene announces that its European Patent EP 2813141 entitled ”Directed strategies for improving phenotypic traits”, was upheld after oral proceedings at the European Patent Office. The patent, granted August 5, 2015, is part of KeyGene’s accelerated molecular breeding estate and protects methods for improving phenotypic traits of interest in crops or animals.

How TEDCO and the Abell Foundation are quietly building Greater Baltimore’s startup ecosystem – Baltimore Business Journal

TEDCO and the Abell Foundation are the might and money behind local startups.

CosmosID Brings Biology into the 21st Century – GEN

“If an 1890s physicist time-travelled to a physics laboratory today, he would be totally flummoxed. But, if Louis Pasteur were transported to a microbiology laboratory just a few years ago, he very likely would have rolled up his sleeves and gone to work. That’s because, compared to physics labs, not much has changed regarding microbial systematics. Microbial systematics—the identification and characterization of microorganisms—simply had to be modernized,” says Rita Colwell, Ph.D., founder of CosmosID.

Stanford, MIT, Johns Hopkins University and Waterloo University eye Hong Kong as regional base for stem cell research | South China Morning Post

Four world-renowned universities are eyeing Hong Kong as a stronghold in Asia for developing cutting-edge stem cell research as the city’s financial chief is expected to announce incentives to make it easier for foreign research institutions to invest in innovation and technology locally, the Post has learned.

The Robert E. Fischell Institute for Biomedical Devices – A. James Clark School of Engineering, University of Maryland

The Robert E. Fischell Institute for Biomedical Devices is bringing together skilled scientists, medical doctors, health practitioners, and bioengineers who are working to research, design, and build biomedical devices to benefit humanity, while simultaneously training the next generation of innovators.

Innovation for Impact Prize – SoBran, Inc.

Tell us about the impact your research may make on the world. You could win a free pre-clinical research study valued up to $20,000 and $1,000 in cash, or additional cash prizes.

SoBran and the Maryland Tech Council are celebrating the transformational science coming out of the Maryland and surrounding area by establishing the Innovation for Impact Prize.

PitchMasters™ announces 2018 dates, seeks entrepreneurs for pitch presentations: Law Firm, Attorneys – Maryland, Washington, DC, Virginia – Shulman Rogers

PitchMasters™, a recently launched event for entrepreneurs preparing to raise their first institutional or ‘A’ round of capital, has announced dates for 2018. The event series aims to bring together four early-stage or start-up companies and experienced entrepreneurs, investors and industry influencers to hone pitching skills, provide practical insights and guidance, and form new network connections. For 2018, PitchMasters seeks participants for its March 7, June 6, September 12 and December 6 events.

Biotech company celebrates move to new Frederick location -fredericknewspost.com

Margot Connor has global ambitions for her company, RoosterBio Inc. But she expects that it will stay connected to its Frederick roots.

GAO: Medicaid experiments aren’t being properly evaluated to determine if they improve care, save money – MedCity News

With federal spending on Medicaid experiments soaring in recent years, a congressional watchdog said state and federal governments fail to adequately evaluate if the efforts improve care and save money.

Public universities band together on completion rates and achievement gaps

A group of 100 public universities will work with the Association of Public and Land-grant Universities to produce hundreds of thousands of additional degrees while also reducing achievement gaps for underrepresented student groups.

10 Breakthrough Technologies 2018 – MIT Technology Review

Dueling neural networks. Artificial embryos. AI in the cloud. Welcome to our annual list of the 10 technology advances we think will shape the way we work and live now and for years to come.

Drinking Red Wine May Help Prevent Tooth Decay and Gum Disease – GEN

Prior research has found that drinking a glass of red wine a day may protect against cardiovascular diseases, diabetes, and neurodegenerative disorders. The latest laboratory studies by researchers in Spain now suggest that the polyphenols in red wine could also protect against the bacteria that cause tooth cavities and gum disease.

The CEO of Merck on Race, Leadership, and High Drug Prices

Kenneth Frazier, the CEO of the pharmaceutical company known as MSD outside of North America, discusses his upbringing and how it influences his leadership as chief executive. He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices.

Startup Professionals Musings: 8 Smart Tips To Soliciting Friends And Family Funding

It’s great to start with a big dream as you contemplate a new business, but finding the money you need takes more than dreaming. As an advisor to young entrepreneurs, I find that many are a bit naïve about how the investment process really works. For example, I just read an otherwise impressive business plan last week from a first-timer who asked for $10 million to get started.

Feb 20 2018

Love0

292nd Edition – February 20, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

February 20, 2018

GlycoMimetics, Inc. Co-Founder & CEO Rachel K. King Interviewed on New Episode of BHI Podcast – BioTalk with Rich Bendis

Rachel K. King, Co-Founder and CEO, GlycoMimetics, Inc. (GMI), joins Rich Bendis for the latest episode of BioTalk. They cover topics from her background in the industry to running a publicly traded company in the BioHealth Capital Region. Before founding GMI, she was an Executive in Residence at New Enterprise Associates (NEA), one of the nation’s leading venture capital firms. Mrs. King came to NEA after serving as a Senior Vice President of Novartis Corporation. She also served as Chairman of International BIO.

Listen now on iTunes , Google Play , and TuneIn.

Tapping into America’s Biomedical Seed Fund

Looking for a deal in your backyard? The NIH is the world’s largest investor in early stage life sciences companies. Over 1000 companies annually tap into NIH’s SBIR and STTR program for nondilutive funding to the tune of $980M in FY17. Did you know the NIH maintains RePORTER, an online database, of all funded companies and projects?

Industry-PostDoc Happy Hour – Feb. 20th

BHI is working with several regional partners to cultivate local biohealth research talent and help those with interest and qualifications transition to industry.

This month, BHI is co-hosting with NCI, WorkSource Montgomery, and BioBuzz two PostDoc-Industry Connections Happy Hours enabling NCI postdocs and others at NIH to learn more about local opportunities in the region’s biohealth industry. Industry participants are invited to attend these complimentary networking receptions and share their thoughts regarding career paths and opportunities in the field.

Registration is free but limited. RSVPs are required. Please RSVP using the following links:

2/20 – 5-7:00 p.m. – JHU Montgomery Campus, Rockville – RSVP here

Save the date: 6/20 – Industry Postdoc Hiring Event – NCI Rockville Campus

Questions/more information?

Win $10,000 at the 2018 BHCR Crab Trap

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

If you are director level or above, please register for 2018 BioHealth Capital Region Forum

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

Mallinckrodt (MNK) Completes Acquisition Of Sucampo Pharmaceuticals (SCMP)

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has closed the acquisition of Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, including its commercial and development assets.

‘Create the next Amazon’ and other thoughts from entrepreneur Steve Case | Hub

Seventy-five years ago, Silicon Valley was fruit orchids and Detroit was dominating the most exciting industry in the nation. “Things can change,” Steve Case said of the tidal shifts of the U.S. innovation economy.

Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio

Swiss drugmaker Roche Holding AG (ROG.S) said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health for $1.9 billion to speed development of cancer medicines and support its efforts to price them based on how well they work.

Why Roche’s $1.9 Billion Deal to Buy Flatiron Health Matters – Fortune

The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D.

Tax Reform Q&A: The Implications for Emerging Growth Enterprises and Start-Ups – WSGR Client Advisory – February 2018

Congress recently enacted the most significant overhaul to the U.S. Internal Revenue Code (the Code) in decades. The legislation, commonly known as the Tax Cuts and Jobs Act (the Act), includes a number of changes to the Code that apply to corporate and pass-through businesses. This Q&A summarizes the key tax and employee benefits changes in the Act that impact domestic emerging growth enterprises and start-ups. For additional information on the Act, see our prior alerts: Congress Passes Tax Cuts and Jobs Act and U.S. House and Senate Pass Reconciled Tax Cuts and Jobs Act.

FDA’s Scott Gottlieb wants to use funding boost to create a Center of Excellence on Digital Health | FierceHealthcare

The Food and Drug Administration plans to use a proposed $400 million boost in federal funding to focus on a range of innovative approaches to speed the approval of new medical devices and create a new center that would support digital health oversight and address cybersecurity concerns.

Startup Maryland Announces Finalists for the 2017 STRT1UP Roadshow + Pitch Across Maryland

Startup Maryland today unveiled the Overall Great Eight and other sub-category finalist for the Pitch Across Maryland Competitions. Startup Maryland is proud to showcase the finalists along with all the ventures who participated in the 2017 STRT1UP Roadshow celebration of innovation and entrepreneurship. This year’s Overall Great Eight Finalist are listed below with a link to their pitch video.

Kevin Plank’s First LinkedIn Article Teaches an Unforgettable Lesson About Entrepreneurship | Inc.com

A lot of great things happened this Valentine’s Day – countless couples celebrated their love with chocolate, roses, and dates. However, there was one thing that stood out to me: Under Amour CEO Kevin Plank posted his first LinkedIn article.

NHLBI Funding & Research Opportunities and Announcements for February 2, 2018

Weekly NIH Funding Opportunities and Notices

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

NIH funding fewer clinical trials, Johns Hopkins study shows – Baltimore Sun

The National Institutes of Health has been funding fewer clinical trials in recent years, according to new Johns Hopkins University research.

Please join the BioPark’s Monthly Networking Event

Host: UM BioPark & Wexford Science + Technology

Location: UM BioPark The Nook Cafe 801 W. Baltimore Street Baltimore Maryland 21201

Time: Thursday, February 22, 2018 5:00pm to 6:30pm

Mingle with BioPark tenants, our UM Ventures staff, UMB faculty and leaders in Baltimore’s technology community.

NextGen Venture Partners Joins Brown Advisory

Brown Advisory—an investment and strategic advisory firm committed to making a material and positive difference in the lives of its clients—is excited to join forces with network-driven venture capital firm, NextGen Venture Partners (“NextGen”). On Feb. 22, 2018, the NextGen team will officially join their new Brown Advisory colleagues in offices across the United States.

Dr. Richard Douglas Joins MaxCyte Board

MaxCyte, the global cell-based medicines and technology company, announces that 30-year life sciences industry veteran Richard Douglas, Ph.D., has been appointed to the Company’s Board of Directors as an Independent Non-Executive Director.

PIERIS PHARMACEUTICALS ANNOUNCES PRICING OF ITS PUBLIC OFFERING

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, announced today the pricing of its previously announced underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $8.00 per share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Pieris, are expected to be $44.0 million. In addition, Pieris has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about February 16, 2018, subject to customary closing conditions.

BIO turns 25 – Innovators magazine

The Biotechnology Innovation Organization (BIO) celebrates its 25 years anniversary this year.

Innovators Magazine is a media partner with one of BIO’S flagship annual events, the World Congress on Industrial Biotechnology, and we’ve distributed special Congress editions at the last two instalments, in San Diego and Montréal.

Johns Hopkins researchers teach robots how to move using cockroaches

Researchers at Johns Hopkins University believe robots could learn a thing or two from nature’s most adaptable pest — the cockroach. The insect can navigate almost any terrain, thanks to over 300 million years of evolution. Scientists filmed the cockroaches running obstacle courses and captured their movements using high-speed cameras. The footage was then analyzed and adapted for a six-legged robot to repeat the movements. Researchers hope this work can eventually be used in search and rescue missions during natural disasters.

D.C. Issues Permit In NoMa For Elon Musk’s Tunnel-Building Company – Construction & Dev

Elon Musk’s plan to build a hyperloop tunnel to allow travel from D.C. to New York in under 30 minutes appears to be gaining traction with District officials.

A New Material Called “Superwood” Is Just As Strong As Steel

Is wood the next advanced material?

Scientists at the University of Maryland reported last week that they’ve discovered a way to treat wood to make it 12 times stronger than natural wood and 10 times tougher. According to Liangbing Hu, one the lead researchers in the paper published in Nature, their wood is so strong and durable that it can compete with steel, titanium alloys, and even carbon fiber–but at an infinitely much lower price point.

WIB-Capital Region Presents: “Raising Venture Capital in Biotech” RegisterTell a Friend About This EventTell a Friend

Join WIB–Capital Region on February 21, 2018 for a panel discussion with industry experts that will help demystify venture capital funding in the biotech space.Join WIB–Capital Region on February 21, 2018 for a panel discussion with industry experts that will help demystify venture capital funding in the biotech space.

Moderated by Crystal Icenhour; CEO, Aperiomics, and featuring panelists Kyp Sirinakis, Managing Partner, Expidarex Capital, and Laurie Silver, CFO, Brainscope, this session is intended to be highly interactive! In addition to having questions in mind for the Q&A session, we encourage you to send questions in advance to capitalregion@WomenInBio.org to help guide the discussion.

Feb 13 2018

Love0

291st Edition – February 13, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

February 13, 2018

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

If you are director level or above, please register for 2018 BioHealth Capital Region Forum

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

BHI Working to Grow Entrepreneurial Talent Pool – 2/15 & 2/20 Happy Hours

BHI is working with several regional partners to cultivate local biohealth research talent and help those with interest and qualifications transition to industry.

Registration is free but limited. RSVPs are required. Please RSVP using the following links:

2/15 – 6-8:00 p.m. – Waverly St. Gallery, Bethesda – RSVP here

2/20 – 5-7:00 p.m. – JHU Montgomery Campus, Rockville – RSVP here

Save the date: 6/20 – Industry Postdoc Hiring Event – NCI Rockville Campus

Questions/more information?

Teva Pharmaceuticals chairman, former Medtronic CEO invest in NexImmune – Washington Business Journal

The company overcame early funding challenges with the help of influential backing.

Rexahn Pharmaceuticals Announces Collaboration with Zhejiang Haichang Biotechnology Co., Ltd. for the Development of RX-0201 (Archexin®) for the treatment of Hepatocellular Carcinoma (NYSE:RNN)

Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced that it has entered into a collaboration and license agreement with Zhejiang Haichang Biotechnology Co., Ltd. (Haichang), to develop RX-0201 (Archexin®) for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.

Camden Partners Nexus leads Series D funding for eNeura – Technical.ly Baltimore

eNeura, a Baltimore-based company that makes a device to treat migraines, closed a Series D investment round.

TEDCO adds five companies to seed portfolio with $600,000 in new investments – Baltimore Business Journal

Maryland Technology Development Corp. made new seed investments in five Maryland startup companies, totaling $600,000.

TEDCO has invested hundreds of thousands of dollars in young, growing companies across the state. The state-backed organization has 137 active investments through its seed fund.

MD Momentum Fund Backs Stroke Recovery Firm – University of Maryland, Baltimore

The University System of Maryland (USM) has selected NextStep Robotics, a startup company that has developed a personalized robotic therapy to help relieve discomforts of “foot drop” syndrome in recovering stroke patients, as recipient of the second investment from the recently established Maryland Momentum Fund.

GlycoMimetics Enters into Agreement with HOVON to Initiate Study Startup Activities for Planned Clinical Trial of GMI-1271 and Decitabine in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Unfit for Chemotherapy | GlycoMimetics, Inc.

GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that it has entered into an agreement with the Haemato Oncology Foundation for Adults in the Netherlands (HOVON) groupto initiate clinical trial startup activities. In the planned clinical trial, HOVON researchers will evaluate GlycoMimetics’ drug candidate, GMI-1271, in adults with newly diagnosed acute myeloid leukemia (AML) but who cannot tolerate intensive chemotherapy, as well as in patients with myelodysplastic syndrome (MDS) with a high risk of leukemia. The HOVON Central Office has already approved a protocol concept, and this agreement enables HOVON to commit staff to the planned trial in order to finalize the protocol, start regulatory and ethics reviews, and begin development of the database. Separately, GlycoMimetics said it plans to announce the design details for its company-sponsored Phase 3 trial in relapsed/refractory AML patients as part of its fourth-quarter and year-end 2017 earnings call scheduled for March 6, 2018.

Orgenesis and Adva Biotechnology to Develop and Distribute Advanced Automated Culturing System for Cell Therapy Manufacturing | StockGuru SmallCap Alerts on Penny Stocks

Orgenesis Inc., (OTCQB:ORGS), a service and research company in the field of the regenerative medicine industry with a focus on cell therapy development and manufacturing for advanced medicinal products, today announced it has entered into an agreement with Adva Biotechnology Ltd., an innovator of enhanced bioprocessing solutions, for the development of an automated culturing system for use in the provision of contract manufacturing services, as well as Orgenesis’s therapeutic development. This system has the potential to enable cost-efficient and automated manufacturing for autologous cell therapies.

The Convergence of Medicine and Technology – PharmaVOICE

Imagine instead of a pill, a doctor prescribes a game for a child with attention deficit disorder. Or imagine patients dealing with substance abuse being prescribed assessments they can do via a mobile device to track progress.

Frederick’s Mid-Atlantic Angels Optimistic for Year Ahead

Mid-Atlantic Angels, LLC (MAA) approaches its 2018 programming in an environment of economic optimism that leverages the economic upsurge of 2017. With the strengthening economy and accompanying confidence, angel investment is expected to surge and contribute to the growth of a vibrant regional economic landscape. The aim is to help create successful businesses while generating a return on investment for MAA member investors. In addition to scheduling a full slate of five Capital Cycles for 2018 in which entrepreneurial companies pitch for capital, MAA is adding more investor members, has lined up a valuable series of investor/entrepreneur workshops, has established a cadre of loyal sponsor organizations, is increasing its outreach to investment and entrepreneurial oriented organizations in the Frederick region, and is expanding its Board to better meet the needs of MAA and its communities.

Explore Videos of Groundbreaking Research and Discovery in our Backyard — MCEDC

Top life science companies perform cutting-edge research and make transformational discoveries throughout the County from the I-270 corridor of Gaithersburg and Germantown to White Oak. Add in the federal presence of the NIH and FDA, along with top talent, and tap into our strong momentum for BioHealth success. The business models vary yet our companies have important assets in common: a commitment to diversity of people, places and ideas and a spirit of innovation. Meet some of our impressive CEOs and company heads that showcase life science excellence in the County in our Think Success video series.

The University of Maryland is getting a new $50 million engineering building – The Diamondback

The University System of Maryland Board of Regents voted on Friday to approve the construction of a new engineering facility on the University of Maryland’s campus.

Shepherd Entrepreneurship and Research Corporation achieves nonprofit status | News, Sports, Jobs – Journal News

Shepherd University has created a new nonprofit organization with a mission of helping facilitate research, innovation, and entrepreneurship. On January 24, the Internal Revenue Service approved the Shepherd Entrepreneurship and Research Corporation’s (SERC) status as a 501(c)(3).

New report highlights New York City’s health tech and life science investment landscape – MedCity News

By StartUp Health’s reckoning, New York City was the second most active city for health tech dealflow in 2017 with $1 billion invested across 63 deals. San Francisco had nearly twice the number of deals and more than three times the amount, but the closest to New York was Boston with 29.

BioBuzz with BioIT Solutions in Rockville on Feb 13th!

When: Tuesday, February 13, 2018 from 5:00 PM to 7:00 PM EST

Where: Bar Louie 150 Gibbs St Rockville, MD 20850

Join BioBuzz and sponsor BioIT Solutions in Rockville at Bar Louie on February 13th, 2018 from 5 – 7pm. Only a 5 minute walk from the Rockville Metro, please join us for this exciting event. BioIT Solutions offers a range of services from enterprise systems built on their 1Platform4® Suite for advanced computational, workflow, and data management systems to IT strategy, architecture and management consulting. The 1Platform4® Suite consists of a software foundation on which various highly configurable modules are assembled and tailored to each client’s specifications and needs.

The 19 Biggest Venture Deals of 2017 (and early 2018) – BuiltWorlds

Dovetailing off our Top 27 Venture Players report, we’ve put together the 19 largest AEC and real estate venture rounds of the past year. There were plenty of surprises.

WIB-Capital Region Presents: “Raising Venture Capital in Biotech”

Join WIB–Capital Region on February 21, 2018 for a panel discussion with industry experts that will help demystify venture capital funding in the biotech space.

Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines

Lonza Pharma & Biotech and Denali Therapeutics (NASDAQ: DNLI) announced today an exclusive strategic partnership on Denali’s biologic pipeline products for neurodegenerative diseases. The agreement covers all stages of the development and manufacturing,

11 Startups with JHTV Ties Rank Among Baltimore’s Best – JHTV

In the last six months, Personal Genome Diagnostics (PGDx) raised a $75 million series B, Harpoon Medical sold for $100 million and Sunayu acquired Fractal Technology. Which Baltimore startup is next?

Researchers Develop Breakthrough Technique to Combat Cancer Drug Resistance – Fischell Department of Bioengineering

The ability for cancer cells to develop resistance to chemotherapy drugs – known as multidrug resistance – remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to “turn off” their resistance capabilities.

ABL Europe and SillaJen Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies – ABL, Inc.

SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, and ABL Europe, an ABL, Inc. company providing dedicated viral vector GMP services for gene therapy, oncolytic products and vaccines for all stages of clinical supply, have expanded their strategic manufacturing collaboration. Under the current agreement, ABL is currently manufacturing Pexa-Vec (formerly JX-594) for SillaJen’s multinational, randomized Phase 3, open-label study of Pexa-Vec in patients with advanced liver cancer. Under the expanded agreement, ABL will also provide development, manufacturing & QC release testing services for SillaJen’s pipeline product, JX-970.

Feb 07 2018

Love0

290th Edition – February 6, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

February 7, 2018

2018 BioHealth Capital Region Forum

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

2018 BHCR Crab Trap

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum.

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

BHI Working to Grow Entrepreneurial Talent Pool – 2/15 & 2/20 Happy Hours

BHI is working with several regional partners to cultivate local biohealth research talent and help those with interest and qualifications transition to industry.

In February, BHI is co-hosting with NCI, and WorkSource Montgomery two PostDoc-Industry Connections Happy Hours enabling NCI postdocs and others at NIH to learn more about local opportunities in the region’s biohealth industry. Industry participants are invited to attend these complimentary networking receptions and share their thoughts regarding career paths and opportunities in the field.

Registration is free but limited. RSVPs are required.Please RSVP using the following links:

2/15 – 6-8:00 p.m. – Waverly St. Gallery, Bethesda – RSVP here

2/20 – 5-7:00 p.m. – JHU Montgomery Campus, Rockville – RSVP here

Save the date: 6/20 – Industry Postdoc Hiring Event – NCI Rockville Campus

Questions/more information?

2/13 Biohealth Industry HR Executives Lunch

Who: BioHealth Industry Hiring Managers/HR Executives

What: Luncheon meeting where you will have the opportunity to:

Provide feedback on a preliminary assessment of regional biohealth hiring needs
Offer input on a proposed compensation survey,
Learn of local resources to assist you in your recruiting and training activities,
Ensure you are among the first to receive copies of the Hiring Needs, and Compensation Survey reports to be published later this Spring.
Network with peers

When: February 13th, 12:00-2:00 p.m.

Where: Universities of Shady Grove (USG)

Hosts: BioHealth Innovation, NCI, WorkSource Montgomery, UMBC, USG

RSVP’s are required. Click HERE to RSVP.

*Due to limited space, this event is for Hiring Managers/industry HR staff only (recruiters/vendors/other excluded). Questions/more information.

New BHI Analyst Chris Moad

Chris started out at BHI as an Analyst Intern through the JHU BioMedical Careers program in September 2017. Chris’ continued passion for translating biomedical research into commercial products and services led him to join BHI as a full time Analyst in February of 2018. Chris supports the Entrepreneurs-in-Residence in evaluating the commercialization potential of new research and technologies, and supporting the BHI portfolio companies through business development and market analysis. He holds a B.S. in Biology from the College of William and Mary and his M.S. in Cellular and Molecular Medicine from the Johns Hopkins School of Medicine.

Steve Case is kicking off a new startup series from Hopkins, University of Maryland – Technical.ly Baltimore

AOL cofounder Steve Case is returning to Baltimore in a couple of weeks in a new event series designed to help entrepreneurs.

Startup with Johns Hopkins roots raising $40.5 million to develop cancer metabolism drugs – Endpoints News

A new oncology company spun out of Johns Hopkins School of Medicine is raising up to $40.5 million to develop its platform of anticancer therapies.

20/20 Closes Record Equity Crowdfunding Campaign

20/20 GeneSystems, Inc. finalized its first equity crowdfunding campaign this week with gross proceeds of $1.07 million, the maximum amount permitted under current SEC rules pursuant to Regulation CF. In so doing, the company became only the second medical technology firm to reach this maximum. 20/20 is now listed as one of the “Top 20 Regulation Crowdfunding Campaigns of All Time” by Crowdfund Capital Advisors. The campaign was posted on First Democracy VC, a joint venture between Indiegogo and MicroVentures and was assisted by marketing firm Enventys Partners.

It’s Time! Sign up to host during 2018 Summer RISE! – Worksource Montgomery

Summer RISE is your chance to impact the future workforce of Montgomery County for three weeks in July. Be the organization that gives real career experiences to County youth and helps them realize the opportunities ahead of them.

OpGen Prices $12M Stock Offering – GenomeWeb

OpGen announced today that it has priced its public offering of approximately 3.7 million units of common stock and common warrants at $3.25 per unit.

Qiagen inks $191M deal to buy infection test panel firm STAT-Dx – FierceBiotech

Qiagen has agreed to a $191 million deal to acquire STAT-Dx. The takeover will give Qiagen control of a pipeline of assay panels designed to diagnose infections affecting the respiratory and gastrointestinal systems.

TEDCO adds five companies to seed portfolio with $600,000 in new investments – Baltimore Business Journal

Maryland Technology Development Corp. made new seed investments in five Maryland startup companies, totaling $600,000.

TEDCO has invested hundreds of thousands of dollars in young, growing companies across the state. The state-backed organization has 137 active investments through its seed fund.

DC Startup News: Tech Startup Funding, Investment in January

In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a lot of it floating around the D.C. metro area, and we cover it everyday in our daily newsletter, The Beat. Here’s a roundup of all of the major funding news from the region in January:

Jeff Immelt, Former CEO And Chairman Of GE, Joins NEA As Venture Partner

Global venture capital firm New Enterprise Associates, Inc. (NEA) today announced that Jeff Immelt has joined the firm as Venture Partner. Immelt, who recently retired from his role as Chairman and CEO of GE after 16 years at the helm of the 125-year-old company, is widely regarded as one of the world’s most innovative and capable business leaders. His extensive domain and company-building expertise are closely aligned with NEA’s core sectors of focus, and he will work closely with technology and healthcare companies across the firm’s portfolio in this new role.

Innate Pharma and MedImmune Test their Cancer Combo in the Clinic

Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid tumors.

Seed fund chooses companies using research and technology developed by U.Va. professors – The Cavalier Daily

The U.Va. Licensing and Ventures group is offering funding to three local health and technology startups.

Johns Hopkins, University of Maryland, Betamore seek 5 health startups for new accelerator – Baltimore Business Journal

Betamore, Johns Hopkins Technology Ventures and the University of Maryland, Baltimore are looking for five local digital health, bio-health or life sciences companies to participate in a new collaborative accelerator program.

Qiagen Snaps Up STAT-Dx to Develop New Diagnostic Tests

Qiagen will acquire Spanish biotech STAT-Dx for up to €153M – more than 3 times the total funding it has raised so far – to produce fast and effective diagnostic tests for infections and cancer.

Influential Marylanders – Maryland Daily Record

March 22, 2018 5:30 – 8:00 p.m.

The Grand Lodge of Maryland 304 International Cir Cockeysville, MD 21030

Influential Marylanders was created to honor individuals who have made significant impacts in their field and continue to be leaders in Maryland. These individuals are selected by The Daily Record’s editors for their significant contributions to their respective fields and for their leadership in Maryland in the following areas: civic leadership; communications; education; finance; freestyle; general business; health care; law; philanthropy; real estate; and technology. Three-time winners are inducted into the Circle of Influence.

NHLBI Funding & Research Opportunities and Announcements for January 19, 2018

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Johns Hopkins University’s FastForward U: A Case Study in Comprehensive Support of Student Entrepreneurship – Tech Transfer Central

At many university TTOs, a historical focus on faculty research has resulted in relatively weak support for the student innovation ecosystem – and it’s a gap that many schools are now rushing to fill. It’s true that many universities hold student innovation contests and offer mentoring programs for the most promising business-minded students. But your TTO can go further by creating an ecosystem with a strong talent pool to not only build valuable start-ups, but keep these young entrepreneurs and their companies in the region, contributing to the local economy and creating an environment that’s attractive to outside investors and industry partners.

Amazon, Berkshire Hathaway and JPMorgan Team Up to Try to Disrupt Health Care – The New York Times

Three corporate behemoths — Amazon, Berkshire Hathaway and JPMorgan Chase — announced on Tuesday that they would form an independent health care company for their employees in the United States.

What Amazon’s Health Care Could Look Like

Amazon made an announcement Tuesday that sent shockwaves through the health care industry and caused insurers’ stocks to plummet: The technology company is joining Berkshire Hathaway and JPMorgan Chase to create an independent health care organization that will serve their employees.

Roche scores an unusual ‘breakthrough’ at the FDA for an autism drug – Endpoints News

The team at Roche’s Basel-based underdog R&D group pRED has something to cheer about today. The FDA has designated their autism drug RG7314 (balovaptan) as a “breakthrough” therapy worthy of VIP treatment at the agency.

Maryland in Top 10 States that Added Jobs (Virginia and DC in Top 30) – Governing.com

Nearly all states added jobs in 2017, but the latest Labor Department data suggests most states experienced slower growth last year than in 2016.

Still, it proved to be a particularly strong year for a select group of states — 10 of which recorded year-over-year job gains exceeding 2 percent.

A guide to venture capital for the individual investor – Baltimore Business Journal

Venture backed companies can address a large market quickly, and therefore payoff investors sooner than other businesses.

Expanding Partnership between University of Maryland and East China University of Science and Technology | Institute for Bioscience and Biotechnology Research

The new year is off to a great start for the partnership between University of Maryland (UMD) and Shanghai’s East China University of Science and Technology (ECUST). This partnership began five years ago when Prof. Greg Payne, from UMD’s Institute for Bioscience and Biotechnology Research (IBBR) and Fischell Department of Bioengineering, was appointed a Chaired Professor in ECUST. The goal of this partnership has been to integrate UMD’s expertise in biofabrication with ECUST’s translational research in biomedical materials. Prof. Changsheng Liu, ECUST’s Vice President and a member of the Chinese National Academy of Sciences, initiated this collaboration as part of ECUST’s efforts to attract international participation in their research programs. “Our work with Maryland has been one of our most successful examples of international collaboration and has led to numerous technical advances while enhancing our graduate student training,” noted Liu.

May’s visit yields US$1.3b in Chinese funds for British biotech and life sciences companies | South China Morning Post

China’s increasing zeal for improving biotechnology and medical services is music to the ears of the British government after two venture capital firms received 8 billion yuan (US$1.3 billion) in funding commitments from mainland investors during Prime Minister Theresa May’s three-day visit last week.

Health Leader Tanisha Carino, Ph.D. Takes Helm as New Executive Director of FasterCures – Milken Institute

Tanisha Carino, Ph.D., the respected senior executive with more than two decades of experience in academia, government, and the private sector, is joining the Milken Institute as executive director of FasterCures, the center devoted to saving lives and improving the medical research system.

In wine, there’s health: Low levels of alcohol good for the brain – ScienceBlog.com

While a couple of glasses of wine can help clear the mind after a busy day, new research shows that it may actually help clean the mind as well. The new study, which appears in the journal Scientific Reports, shows that low levels of alcohol consumption tamp down inflammation and helps the brain clear away toxins, including those associated with Alzheimer’s disease.

2018 Rice Business Plan Competition

One Week Left to Apply!!

Deadline: Friday, February 9, 2018, 5pm

We are looking for the best university startups from schools around the world!

Over $1 million in Prizes! 42 startup teams will be invited to compete in front of hundreds of investors.

Join the more than 200 startups that have been successfully launched after competing at the RBPC and raised more than $1.7 billion!

Competition Dates: April 5-7, 2018

Rice University, HoustonJones Graduate School of Business

Just 30 minutes of light exercise each day can benefit health

A new study from the Karolinska Institutet in Stockholm, Sweden, suggests that replacing time spent sitting with light-intensity physical activity may benefit health more than previously thought.

$1.3 million: The lifetime cost of each young Australian diagnosed with cancer revealed

Sophie Martyr was just 13 years old when she learnt she had brain cancer and was asked to make a decision about whether she wanted to have children in the future.

Jan 30 2018

Love0

289th Edition – January 30, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

January 30, 2018

Third Annual Crab Trap Competition

You thought the Shark Tank was tough?

The Third Annual BioHealth Capital Region Crab Trap is now accepting applications at bit.do/crabtrap!

Deadline for entries is March 30th – Finalists will be announced on April 9th

Submit your application for a chance to be named the startup company with the most commercial potential at the BioHealth Capital Region Forum.

Five finalists will have the chance to win the grand prize by presenting on April 24th in front of a panel of prominent industry funding expert and executives.

Paragon Bioservices aims to create 200 jobs with Maryland expansion – Technical.ly Baltimore

Paragon Bioservices has plans to expand to new space over the next two years to help companies develop and manufacture biopharmaceuticals.

Regenxbio (RGNX) Enters Strategic Partnership with FUJIFILM Diosynth Biotechnologies

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced an agreement with FUJIFILM Diosynth Biotechnologies (FUJIFILM) for the manufacture of REGENXBIO’s lead product candidates, including RGX-314 and RGX-501, which will support late-stage clinical development and early commercialization. This partnership builds on the foundation of REGENXBIO’s internal manufacturing and process development capabilities.

What’s the reaction to Gov. Larry Hogan’s proposed incentives for Amazon? – The Washington Post

Maryland Senate President Thomas V. Mike Miller Jr. (D-Calvert) and Democrats from Montgomery County are rallying around Republican Gov. Larry Hogan’s $5 billion incentive package to lure Amazon.com and a 50,000-person headquarters to the Washington suburb, but it remains to be seen whether the rest of the Democratic-majority legislature will support the package.

University of Maryland Baltimore President Dr. Jay Perman Interviewed on New Episode of BHI Podcast – BioTalk with Rich Bendis

Dr. Jay Perman, President, University of Maryland, Baltimore, joins Rich Bendis for a BioHealth Capital Region conversation. They cover topics from Innovation and Commercialization to Community and Education in the region. Dr. Perman is the sixth President of the University of Maryland, Baltimore. His presidency is marked by a commitment to such issues as interprofessional education, community engagement, innovation and commercialization, and economic development.

Listen now on iTunes , Google Play , and TuneIn.

Paragon Bioservices Bolsters Leadership Ranks with Executive Appointments, New Vice President Hires

Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces today the promotion of key personnel and the addition of two industry veterans to its leadership team. Specifically, the Company appoints Philip Wills, PhD, as Chief Commercial Officer, John Conner as Chief Manufacturing Officer, and William “Bill” Thomas, Jr., PhD, as Chief Scientific Officer, and hires Randy Henrickson as VP of Manufacturing and Dermot McCaul as VP of Information Technology.

Steve Case to lead off new Anchor Ventures speaker series – Maryland Daily Record

AOL co-founder Steve Case will be the inaugural speaker for Anchor Ventures’s speaker series. Anchor Ventures is a collaboration between University of Maryland Ventures and Johns Hopkins Technology Ventures.

Just Released! REDI Annual Report Highlights 2017 Accomplishments

2017 marked continued growth for Rockville Economic Development, Inc. (REDI) and the Maryland Women’s Business Center (MWBC).

We are pleased to highlight our many accomplishments in the 2017 Annual Report, which was released today.

Could this new incubator nurture the next big thing in life sciences? – Cambridge News

Cambridge’s up and coming life sciences firms will be able to benefit from the expertise of some of the biggest names in the sector at a new bio-incubator and life science accelerator.

QIAGEN Receives FDA Clearance for JAK2 Diagnostic Test – Technology Networks

QIAGEN announced that it has received clearance for its ipsogen JAK2 RGQ PCR Kit (ipsogen JAK2 assay) from the U.S. Food and Drug Administration (FDA) for additional use in the diagnosis of all myeloproliferative neoplasms (MPNs), which are a group of cancers in which immature blood cells in the bone marrow do not mature and become healthy blood cells.

Johns Hopkins U creates new test to screen for 8 cancers – WBFF

Researchers with the Johns Hopkins University School of Medicine developed a new blood test able to screen for eight types of cancers.

Startups: One Entrepreneur’s View of Balancing Passion with Practicality | UM Ventures

Richard Hughen’s first entrepreneurial experience was as Managing Director at e-learning startup LearnWare, where he says his “addiction” to startups began in earnest. The former manager at Abbott Diagnostics, Cordis and Johnson & Johnson enjoyed LearnWare for the very reason that entrepreneurs usually get hooked: building something from scratch is exhilarating

Startup fundraising and exits look bullish for bio and health | TechCrunch

After nearly a year, venture capitalists nabbed their first U.S. acquisition for more than a billion dollars. And it wasn’t a tech startup. Nor was it a company on the list of known unicorns. And it had nothing to do with blockchain.

ETC’S ACCELERATE BALTIMORE ANNOUNCES APPLICATIONS ARE OPEN FOR THE SEVENTH YEAR OF ITS SEED STAGE ACCELERATOR — Accelerate Baltimore

The ETC (Emerging Technology Centers), Baltimore City’s award-winning technology and innovation centers, announces the Accelerate Baltimore (AB) program will run for its seventh consecutive year and applications are now open. The ETC will select six tech startups for the 13-week program set to begin mid-March. The Abell Foundation has awarded ETC $250,000 in funding for this seed accelerator for the third year in a row. Based on the model of last year’s successful program, each of this year’s AB winners will be awarded $25,000 in seed stage funding, while one company will be awarded an additional $100,000 in follow on funding at the end of the program.

Apply by Feb 12th for Unique Pediatric Surgical Innovation Fellowship at Children’s National

The Joseph E. Robert, Jr., Fellowship in Pediatric Surgical Innovation is an exciting and dynamic post-graduate research experience focused on biomedical innovation.

We invite individuals from the following groups to apply for this unique opportunity:

Surgical, radiological, or anesthesia residents, fellows, junior faculty, and nurses
Post-doctoral engineers with a strong background and interest in medical and surgical device development
Post-doctoral or doctoral candidates in Health Economics

American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure | American Gene Technologies

American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its HIV Functional Cure automated cell processing protocol. This completes a key milestone of AGT’s planned Phase I clinical trial of AGT103-T, a genetically modified autologous T cell product in development as an HIV functional cure.

Expanding Partnership between University of Maryland and East China University of Science and Technology | Institute for Bioscience and Biotechnology Research

Health Leader Tanisha Carino, Ph.D. Takes Helm as New Executive Director of FasterCures – Milken Institute

Maryland in Top 10 States that Added Jobs (Virginia and DC in Top 30) – Governing.com

Nearly all states added jobs in 2017, but the latest Labor Department data suggests most states experienced slower growth last year than in 2016.

Still, it proved to be a particularly strong year for a select group of states — 10 of which recorded year-over-year job gains exceeding 2 percent.

Venture capital vital to future of biotech – Laboratory News

The Association of the British Pharmaceutical Industry has released a report suggesting that pharma companies investing in emerging start-ups is now a key source of capital for biotech innovation in the UK.

What’s next for biotech? – Innovators magazine

Innovators Magazine asked some biotech stakeholders what trends they expect to see in their markets this year.

The opinions were published in our special biotechnology edition, which was distributed to delegates at an industry conference in Glasgow this week.

Sanofi to Acquire Biogen Spin-Off in $11.6-Billion Deal | BioPharm International

On Jan. 22, 2018, Sanofi announce that it has entered into a definitive agreement to acquire all outstanding shares of Bioverativ, the hemophilia and blood disorders-focused spin-off company of Biogen, for $105 per share, or a transaction value of approximately $11.6 billion. The transaction was unanimously approved by the boards of directors of Sanofi and Bioverativ.

California Life Sciences Association Applauds Confirmation of Alex Azar as HHS Secretary – Business Wire

California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today commended the U.S. Senate’s confirmation of Alex M. Azar, II as the new secretary of the U.S. Department of Health and Human Services (HHS).

New York sketches out $500M plan to build a biotech hub – FierceBiotech

New York City is doubling down on its long-discussed, never-realized dream of building a biotech hub to rival South San Francisco and Boston. The latest iteration of the dream comes backed by a $500 million financing package and a goal to quadruple the amount of R&D space in the city.

Anatomy of two biotech deals worth $20B – MedCity News

Analysts had forecast a blockbuster year for life science mergers and acquisitions as the lower tax rate for repatriated cash kicks-in and Big Pharma continues its hunt for late-stage assets.

Pursuing breakthroughs in cancer-drug development | McKinsey & Company

The pharmaceutical industry continues to pursue the discovery of medicines for cancer patients with unprecedented rigor. Over the past several years, three major trends have reflected this pursuit. They include the growth of the industry pipeline of cancer-drug candidates, the evolution of the clinical-trial landscape, and the explosion of available clinical and real-world data

BHI Weekly Newsletter Archives

About BioHealth Innovation

Contact

Connect

Search